News Daily News Stroke Protection Holds Up Long-term After LAA Closure: NCDR/Medicare Data Caitlin E. Cox August 15, 2025
News Daily News Little Pre- and Postmarket Testing for Most Recalled CV Devices Michael O'Riordan September 16, 2024
News Daily News FDA to Add New Diversity Requirements for Certain Clinical Studies Todd Neale July 15, 2024
News Conference News SCAI 2024 Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows L.A. McKeown May 06, 2024
News Daily News AHA Sums Up AI’s Potential in Cardiology, but Also the Hurdles Ahead Yael L. Maxwell March 07, 2024
News Conference News HFSA 2023 ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT Yael L. Maxwell October 16, 2023
News Daily News Women and Minorities Underrepresented in Heart Valve Trials L.A. McKeown July 27, 2023
News Daily News The More Tweaks Made to PMA-Approved Devices, the More Likely a Recall Caitlin E. Cox April 13, 2023
News Daily News RECORD4 Trial of Rivaroxaban, Published in 2009, Still Turning Heads Todd Neale January 19, 2023
News Daily News More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials Michael O'Riordan October 28, 2022
News Daily News FDA: New Fix Available for Medtronic’s Troubled HeartWare VADs Michael O'Riordan October 17, 2022
News Daily News Most Patient-Reported Outcome Measures in CVD Fall Short L.A. McKeown September 23, 2022
News Daily News Postmarketing Studies of CV Devices Still Lacking in the US Caitlin E. Cox March 17, 2022
News Daily News Skipping Low-Value Cardiovascular Care Could Save Billions: AHA Michael O'Riordan March 01, 2022
News Daily News Nonfatal MI Not a Death Surrogate in Cardiology: Meta-analysis Caitlin E. Cox October 27, 2021
News Daily News Class I Recall for Cordis’ Super Torque Catheters with Radiopaque Markers Michael O'Riordan September 23, 2021
News Daily News VASCADE Closure Device: FDA Database Tracks Common Complications, Deaths Caitlin E. Cox September 10, 2021